Evidence-based reporting, clinical research breakthroughs, doctor interviews, and validated wellness guides in Diabetes.
Medically Verified Hub
Reviewed by board-certified physicians
A Reuters report published on 16 October described a six-month trial in which continuous glucose monitoring helped adults with type 2 diabetes who were not using insulin improve their blood-sugar measurements. The trial was sponsored by device maker Dexcom.
Showing 14 articles
UC Davis Health reported on 15 October that a pilot remote-monitoring programme helped children and young people with type 1 diabetes improve blood-glucose management between clinic visits.
A study reported by Reuters on 16 October found that continuous glucose monitoring (CGM) helped adults with type 2 diabetes who were not using insulin improve their blood-sugar measurements compared with routine care. The trial was sponsored by the device manufacturer Dexcom.
Research reported on 15 October 2026 examined the relationship between primary care provider resources and health outcomes among people with type 2 diabetes. The findings highlight the importance of accessible primary care, regular monitoring, and continuity of treatment for a disease that can cause serious complications when blood glucose remains poorly controlled. The report focuses on healthcare delivery rather than establishing a new diabetes medication or treatment.
Recent medical research coverage highlighted a trial comparing a high-fiber dietary intervention with metformin for blood sugar and weight outcomes. The findings suggest that dietary composition may play an important role in metabolic management. However, the available summary does not provide enough verified information about the trial's participants, treatment duration, effect sizes, or full statistical results to conclude that a high-fiber diet is generally superior to metformin.
A health report published by The Indian Express on 14 October 2026 explains why two people with the same body mass index may have different risks of metabolic disease. Differences in abdominal fat, muscle mass, and body composition can influence insulin sensitivity and cardiovascular health. The report highlights the importance of evaluating overall metabolic health rather than relying exclusively on body weight or BMI.
The RESET for Remission trial investigated a structured exercise program alongside an intensive low-energy diet in adults with early-onset type 2 diabetes and obesity. Researchers reported improvements in fitness and metabolic health, with muscle mass largely maintained despite substantial weight loss. The findings highlight why exercise programs designed around both aerobic capacity and muscle strength may be important for people managing metabolic disease. University of Leicester
Research from the RESET for Remission trial found that 27 of 50 participants receiving a low-energy diet and structured exercise achieved type 2 diabetes remission after 24 weeks, compared with 2 of 46 participants receiving usual care. The intervention combined a supervised low-calorie diet with aerobic and resistance exercise. The findings suggest that carefully supervised lifestyle interventions may help selected younger adults with type 2 diabetes improve metabolic health and reduce their reliance on glucose-lowering medication.
Researchers at Maastricht University Medical Center reported that longer-term consumption of unsalted, skin-roasted peanuts was associated with improved brain insulin responsiveness. The findings offer an additional perspective on the relationship between dietary habits and metabolic health.
Clinical research indicates that eating vegetables, protein or fat before carbohydrate-rich foods can moderate post-meal blood-glucose increases. This approach is attracting attention as a possible addition to established diabetes-management strategies.
A new medical report highlights the particular dangers of severe hypoglycemia in older adults, who may have reduced awareness of warning symptoms and additional health conditions that increase the risk of complications.
A randomized clinical trial published in Nature Medicine evaluated the oral GLP-1 receptor agonist safiglipron in people with early type 2 diabetes, providing new evidence for orally administered GLP-1 treatment.
Recent research using UK Biobank data found associations between retinal neurodegenerative changes and HbA1c levels below the current diagnostic threshold for prediabetes, raising questions about how early metabolic changes may affect the nervous system.
